What is Bivalirudin?

The short answer

Bivalirudin is a peptide, a short chain of amino acids. In the US, you need a prescription to get Bivalirudin.

Get updates on Bivalirudin

What it is

Type
Direct thrombin inhibitor (peptide)
Also known as
angiomax

Regulatory status

FDA-approved (Rx) How we label status

As of October 4, 2026, Bivalirudin is an FDA-approved prescription drug for anticoagulant in percutaneous coronary intervention.

See Bivalirudin in the Index →

Federal (FDA)
Approved Rx (Angiomax NDA020873, 2000)
503A compounding
Approved-drug component (not in any 503A category) (as of May 14, 2026)

References

Sources as of October 4, 2026

  1. DailyMed: dailymed.nlm.nih.gov/dailymed/drugInfo.cfm